Cargando…
Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series
The current COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). A better understanding of its immunogenicity can be important for the development of improved diagnostics, therapeutics, and vaccines. Here, we report the longitudinal analysis of three COVID...
Autores principales: | Heidepriem, Jasmin, Dahlke, Christine, Kobbe, Robin, Santer, René, Koch, Till, Fathi, Anahita, Seco, Bruna M. S., Ly, My L., Schmiedel, Stefan, Schwinge, Dorothee, Serna, Sonia, Sellrie, Katrin, Reichardt, Niels-Christian, Seeberger, Peter H., Addo, Marylyn M., Loeffler, Felix F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067489/ https://www.ncbi.nlm.nih.gov/pubmed/33917609 http://dx.doi.org/10.3390/pathogens10040438 |
Ejemplares similares
-
Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
por: Fathi, Anahita, et al.
Publicado: (2019) -
Sex Differences in Immunity: Implications for the Development of Novel Vaccines Against Emerging Pathogens
por: Fathi, Anahita, et al.
Publicado: (2021) -
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome
por: Fathi, Anahita, et al.
Publicado: (2022) -
On‐Chip Neo‐Glycopeptide Synthesis for Multivalent Glycan Presentation
por: Mende, Marco, et al.
Publicado: (2020) -
Rapid Response
to Pandemic Threats: Immunogenic Epitope
Detection of Pandemic Pathogens for Diagnostics and Vaccine Development
Using Peptide Microarrays
por: Heiss, Kirsten, et al.
Publicado: (2020)